aTYR PHARMA INC (ATYR)
Data as of , from SEC Form 4 filings.
See up to 3 months of ATYR. The 7-day demo opens the 1M and 3M ranges and puts ATYR on your watchlist.
Start 7-day demoLatest ATYR insider trades
- Paul SchimmelOpen-market purchase$50K
Sanjay Shukla - OfficerOpen-market sale$4K- Jill Marie Broadfoot
About aTYR PHARMA INC (ATYR)
aTYR PHARMA INC is an SEC registrant, filing under CIK 0001339970, classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
ATYR Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 410,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ATYR insider transactions (Form 4)
2417 Form 4 filings on record, the earliest from Dec 12, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Brandon Yaras - Officer | Grant or award | Employee Stock Option (right to buy) | 410,000 | $0.00 | - | |
| Paul Schimmel | Open-market purchase | Common Stock | 100,000 | $0.50 footnote F1 | $50K | |
| ||||||
| Timothy Coughlin | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Eric Benevich | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
 Jane A. Gross | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Svetlana Lucas | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
 Sara Zaknoen | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Paul Schimmel | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Sanjay Shukla - Officer | Option exercise | Common Stock | 10,375 | - footnote F2 | - | |
| Sanjay Shukla - Officer | Open-market sale | Common Stock | 3,745 | $0.98 | $4K | |
| Sanjay Shukla - Officer | Option exercise | Restricted Stock Unit | 10,375 | $0.00 | - | |
| ||||||
| Jill Marie Broadfoot - Officer | Option exercise | Common Stock | 3,750 | - footnote F2 | - | |
| Jill Marie Broadfoot - Officer | Open-market sale | Common Stock | 1,558 | $0.98 | $2K | |
| Jill Marie Broadfoot - Officer | Option exercise | Restricted Stock Unit | 3,750 | $0.00 | - | |
| ||||||
| Nancy Denyes - Officer | Option exercise | Common Stock | 2,687 | - footnote F2 | - | |
| Nancy Denyes - Officer | Open-market sale | Common Stock | 1,118 | $0.98 | $1K | |
| Nancy Denyes - Officer | Option exercise | Restricted Stock Unit | 2,687 | $0.00 | - | |
| ||||||
| Sanjay Shukla - Officer | Grant or award | Employee Stock Option (right to buy) | 1,500,000 | $0.00 | - | |
| Jill Marie Broadfoot - Officer | Grant or award | Employee Stock Option (right to buy) | 412,500 | $0.00 | - | |
| Nancy Denyes - Officer | Grant or award | Employee Stock Options (right to buy) | 412,500 | $0.00 | - | |
| Paul Schimmel | Open-market purchase | Common Stock | 682,001 | $0.90 footnote F1 | $612K | |
| Paul Schimmel | Open-market purchase | Common Stock | 317,999 | $0.94 footnote F3 | $299K | |
| ||||||
| Paul Schimmel | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Eric Benevich | Grant or award | Stock Option (right to buy) | 100,000 | $0.00 | - | |
ATYR insider trading FAQ
What is the latest insider trade for ATYR?
aTYR PHARMA INC (ATYR) had 1 insider filing in the last 90 days, with the most recent on 2026-10-01. The full record for ATYR runs to 17 Form 4 filings, the earliest from 2024-12-12. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ATYR stock?
No insider purchases of ATYR were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling ATYR stock?
No insider sales of ATYR were filed in the last 90 days. 3 sales are on record for this company.
Where can I see ATYR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ATYR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Brandon Yaras view on EDGAR
- - Paul Schimmel view on EDGAR
- - Timothy Coughlin view on EDGAR
- - Eric Benevich view on EDGAR
- - Jane A. Gross view on EDGAR
- - Svetlana Lucas view on EDGAR
- - Sara Zaknoen view on EDGAR
- - Paul Schimmel view on EDGAR
- - Sanjay Shukla view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ATYR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ATYR with a 7-day demo
- ATYR on your watchlist
- Every ATYR Form 4 filing on record
- Up to 3 months of ATYR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
